CHI3L1/YKL-40-associated genes
Gene . | Fold change . | . | |
---|---|---|---|
. | Cells . | Tumors . | |
Ovalbumin | 72.8 | 1.5 | |
Nicotinamide N-methyltransferase | 11.3 | 4.1 | |
Collagen, type VI, α1 | 4.7 | 1.7 | |
Collagen, type VI, α2 | 4.7 | 2.8 | |
Tenascin C (hexabrachion) | 3.9 | 2.4 | |
Basic helix-loop-helix domain containing, class B, 2 | 2.4 | 1.7 | |
Epithelial membrane protein 1 | 2.4 | 1.6 | |
Insulin-like growth factor binding protein 5 | 2.3 | 2.2 | |
Collagen, type XVI, α1 | 2.1 | 2.2 | |
Likely orthologue of rat brain specific binding protein/Ras-induced senescence 1 | 1.9 | 2.1 | |
Transforming growth factor-β receptor II | 1.8 | 1.6 | |
Vascular endothelial growth factor | 1.9 | 2.6 | |
Transforming growth factor β-induced | 1.8 | 2.5 | |
A kinase (PRKA) anchor protein 11 | 1.7 | 1.9 | |
Cadherin 11, type 2, OB-cadherin (osteoblast) | 1.7 | 1.8 | |
Pre-B-cell colony-enhancing factor | 1.7 | 4.5 | |
ADP-ribosylation factor-like 7 | 1.6 | 1.7 | |
KIAA0062 protein | 1.6 | 1.7 | |
Caldesmon 1 | 1.5 | 1.8 | |
Plasminogen activator inhibitor type 1 | 1.5 | 2.6 | |
Paternally expressed 10 | 0.5 | 0.4 |
Gene . | Fold change . | . | |
---|---|---|---|
. | Cells . | Tumors . | |
Ovalbumin | 72.8 | 1.5 | |
Nicotinamide N-methyltransferase | 11.3 | 4.1 | |
Collagen, type VI, α1 | 4.7 | 1.7 | |
Collagen, type VI, α2 | 4.7 | 2.8 | |
Tenascin C (hexabrachion) | 3.9 | 2.4 | |
Basic helix-loop-helix domain containing, class B, 2 | 2.4 | 1.7 | |
Epithelial membrane protein 1 | 2.4 | 1.6 | |
Insulin-like growth factor binding protein 5 | 2.3 | 2.2 | |
Collagen, type XVI, α1 | 2.1 | 2.2 | |
Likely orthologue of rat brain specific binding protein/Ras-induced senescence 1 | 1.9 | 2.1 | |
Transforming growth factor-β receptor II | 1.8 | 1.6 | |
Vascular endothelial growth factor | 1.9 | 2.6 | |
Transforming growth factor β-induced | 1.8 | 2.5 | |
A kinase (PRKA) anchor protein 11 | 1.7 | 1.9 | |
Cadherin 11, type 2, OB-cadherin (osteoblast) | 1.7 | 1.8 | |
Pre-B-cell colony-enhancing factor | 1.7 | 4.5 | |
ADP-ribosylation factor-like 7 | 1.6 | 1.7 | |
KIAA0062 protein | 1.6 | 1.7 | |
Caldesmon 1 | 1.5 | 1.8 | |
Plasminogen activator inhibitor type 1 | 1.5 | 2.6 | |
Paternally expressed 10 | 0.5 | 0.4 |
NOTE: In vivo and in vitro expression patterns for cells overexpressing CHI3L1/YKL-40 were compared. In vivo expression patterns were derived from glioblastoma tumor samples that were divided into two groups based on CHI3L1/YKL-40 expression levels, whereas in vitro profiles were obtained with CHI3L1/YKL-40 and mock-transfected cells. Genes that differed by 1.5-fold in these comparisons and were common to both in vitro and in vivo profiles are shown.